trial

Feasibility and Preliminary Effect of Baduanjin Program for People Diagnosed With Schizophrenia

NCTId NCT04027634
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 22 (actual)
Sponsored by National Yang Ming Chiao Tung University
Primary completion 2014-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
22 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2014-09
Primary completion
2014-12
Eligibility
ALL · 20 Years · 65 Years

Interventions & indications

Drugs
Baduanjin program

Sponsors

National Yang Ming Chiao Tung UniversityLead Sponsor
Taipei Veterans General Hospital, TaiwanCollaborator

Investigators

1
Chiu-Yueh Yang, PhDPrincipal Investigator

Sites

0 total

Facts & assertions

4 sourced
Enrollment
22
Phase
NA
Primary Completion Date
2014-12
Status
COMPLETED
relationships
The graph out of here
drug
Baduanjin program
drug
lead_sponsor
National Yang Ming Chiao Tung University
company
collaborator
Taipei Veterans General Hospital, Taiwan
company
indication
Randomized Controlled Trial
indication
Schizophrenia
indication
investigator
Chiu-Yueh Yang, PhD
person